Application of the 2015/2016 EULAR recommendations for cardiovascular risk in daily practice: data from an observational study
| Autor: | A. Tubery, Guilhem du Cailar, Jacques Morel, Claire Daien, Bernard Combe, Jean Bousquet, Pierre Fesler, François Roubille, Thibault Mura |
|---|---|
| Přispěvatelé: | roussel, pascale, Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Neuropsychiatrie : recherche épidémiologique et clinique (PSNREC), Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Département de Rhumatologie[Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)-Hôpital Lapeyronie, Université de Montpellier (UM), Institut de Génétique Moléculaire de Montpellier ( IGMM ), Université de Montpellier ( UM ) -Centre National de la Recherche Scientifique ( CNRS ), Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ), Neuropsychiatrie : recherche épidémiologique et clinique, Université Montpellier 1 ( UM1 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université de Montpellier ( UM ), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] ( PhyMedExp ), Centre National de la Recherche Scientifique ( CNRS ) -Université de Montpellier ( UM ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Centre Hospitalier Régional Universitaire [Montpellier] ( CHRU Montpellier ) -Hôpital Lapeyronie, Université de Montpellier ( UM ), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Université Montpellier 1 (UM1)-Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS) |
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Male
[SDV]Life Sciences [q-bio] Disease 030204 cardiovascular system & hematology Arthritis Rheumatoid 0302 clinical medicine Risk Factors Daily practice Immunology and Allergy Prospective Studies Risk management ComputingMilieux_MISCELLANEOUS Ultrasonography Middle Aged 3. Good health [SDV] Life Sciences [q-bio] Carotid Arteries Cardiovascular Diseases Rheumatoid arthritis Practice Guidelines as Topic Female medicine.symptom medicine.medical_specialty multimorbidity Immunology EULAR chronic rheumatic disease Risk Assessment Asymptomatic General Biochemistry Genetics and Molecular Biology 03 medical and health sciences European Innovation Partnership on Active and Healthy Ageing Rheumatology Internal medicine Post-hoc analysis medicine Humans cardiovascular diseases Aged 030203 arthritis & rheumatology [ SDV ] Life Sciences [q-bio] business.industry Cholesterol HDL Cholesterol LDL medicine.disease Cardiovascular risk recommendations Physical therapy Observational study Hydroxymethylglutaryl-CoA Reductase Inhibitors business Rheumatism |
| Zdroj: | Annals of the Rheumatic Diseases Annals of the Rheumatic Diseases, 2018, 77 (4), pp.625--626. ⟨10.1136/annrheumdis-2017-211074⟩ Annals of the Rheumatic Diseases, 2018, 77 (4), pp.625--626. 〈10.1136/annrheumdis-2017-211074〉 Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (4), pp.625--626. ⟨10.1136/annrheumdis-2017-211074⟩ |
| ISSN: | 0003-4967 1468-2060 |
| DOI: | 10.1136/annrheumdis-2017-211074⟩ |
| Popis: | The European League Against Rheumatism (EULAR) recently updated the recommendations for cardiovascular disease (CVD) risk management in patients with rheumatoid arthritis (RA).1 In contrast to the 2009 recommendations which advised to multiply by 1.5 the global CVD risk in the presence of certain RA-specific criteria,2 the 2015/2016 update recommends to multiply by 1.5 the global CVD risk for all patients with RA. It also considers the use of carotid ultrasound to screen asymptomatic atherosclerotic plaques. Indeed, the majority of the CVD events occur in the ‘low’ and ‘intermediate’ risk groups and carotid plaque detection to classify patients improves cardiovascular risk prediction.3 The European Society of Cardiology guidelines classify patients with carotid plaque at very high CVD risk.4 Immediate statin use is indicated in those patients if low-density lipoprotein cholesterol is ≥0.7 g/L.4 In a post hoc analysis, we evaluated the impact of the updated 2015/2016 EULAR CVD recommendations … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|